The AMA on 26 March called on all Australian health ministers to reverse a decision by the OBA to allow optometrists to independently manage patients with glaucoma.
AMA president, Dr Steve Hambleton, said the decision puts comprehensive quality care of glaucoma patients at risk.
“The Optometry Board decision goes against the advice of the Pharmaceutical Benefits Advisory Committee and against the wishes of the peak glaucoma support group, Glaucoma Australia,” Dr Hambleton said.
“Glaucoma is known as the ‘sneak thief of sight’, and one in 10 Australians over 80 will develop the disease.
“It is a complex disease that comes in many forms, and requires highly-specialised care over time.
“The Optometry Board has shown that is out of step with best practice care for patients with glaucoma.
“The PBAC recognises the importance of optometrists confirming diagnoses of glaucoma with ophthalmologists, and the need for these two health professions to work together to manage patients with glaucoma, and also recommends the sharing of information with the patient’s GP to complete the clinical team.
“Glaucoma Australia wants the current arrangents for the detection and managent of glaucoma to be maintained.
“Yet the Optometry Board has given the green light for optometrists to go it alone in caring for glaucoma patients.
“This is an irresponsible decision by the board and it must be reversed immediately,” Dr Hambleton said.
Alcon, RxSight collaborating on adjustable IOL for presbyopia
Alcon, a global leader in eyecare, and RxSight, an ophthalmic medical device company providing high-quality customised vision to patients following...
